← NDC auxiliary source history
Current NDC auxiliary source rows
Every current FDA unfinished, excluded, package, product, and compounder source row. Empty or malformed identifiers and report-scoped rows remain addressable by their exact source record and row.
Counts come from the five current base tables. The atomic loader verifies that every base source row has exactly one status projection before publication; directory pages use that verified projection and retain exact base-row detail links.
| Exact source record | Source row | Dataset | Record source | Scope | Status | Status meaning | Product NDC | Package NDC | Product / substance | Application | Reporting period | Normalization | Notes | Source date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
outsourcing:2019-1:576 | 576 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylpropion Hydrochloride; Diazepam | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:576 | 576 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:576 | 576 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:576 | 576 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-229 | 70004-229-32 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:576 | 576 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:576 | 576 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:576 | 576 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:576 | 576 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:576 | 576 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glutathione | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:576 | 576 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6027 | 26436-6027-3 | Fluticasone Propionate; Hydroquinone; Tretinoin | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:576 | 576 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:576 | 576 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1032 | 73013-1032-1 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:576 | 576 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1040 | 73013-1040-1 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:576 | 576 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6521 | 72934-6521-2 | Hydroquinone; Hydrocortisone; Tretinoin | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:576 | 576 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-052 | 73198-052-30 | Inositol; Choline Chloride; Methionine; Cyanocobalamin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:577 | 577 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-6519 | 71266-6519-1 | Phenol in Water | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:577 | 577 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylstilbestrol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:577 | 577 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:577 | 577 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:577 | 577 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-229 | 70004-229-40 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:577 | 577 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:577 | 577 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-1318 | 61141-1318-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:577 | 577 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:577 | 577 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-21 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:577 | 577 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 83343-135 | 83343-135-30 | Glutathione | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:577 | 577 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Foscarnet Sodium | 2023-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-1:577 | 577 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-3011 | 70214-3011-1 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:577 | 577 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-3011 | 70214-3011-1 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:577 | 577 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:577 | 577 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6526 | 72934-6526-2 | Hydroquinone; Tretinoin | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:577 | 577 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-052 | 73198-052-10 | Inositol; Choline Chloride; Methionine; Cyanocobalamin | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:578 | 578 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-2617 | 72934-2617-8 | Divinix | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:578 | 578 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylstilbestrol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:578 | 578 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-9010 | 60652-9010-1 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:578 | 578 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-22 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:578 | 578 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-2 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:578 | 578 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:578 | 578 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2081 | 71286-2081-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:578 | 578 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-546 | 70092-546-35 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:578 | 578 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-303 | 70004-303-17 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:578 | 578 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2403 | 72627-2403-1 | Glutathione | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:578 | 578 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-157 | 73177-157-01 | Furosemide | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:578 | 578 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:578 | 578 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-405 | 70092-405-50 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:578 | 578 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-546 | 70092-546-35 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:578 | 578 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6514 | 72934-6514-2 | Hydroquinone; Tretinoin | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:578 | 578 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-130 | 73198-130-30 | Inositol; Pyridoxine Hydrochloride; Methionine; Riboflavin 5'-Phosphate Sodium Anhydrous; Thiamine Hydrochloride; Choline Chloride | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:579 | 579 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5593 | 26436-5593-3 | Glutamine Arginine HCl Carnitine 25/100/100mg/mL | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:579 | 579 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylstilbestrol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:579 | 579 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:579 | 579 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-231 | 70004-231-32 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:579 | 579 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-3 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:579 | 579 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:579 | 579 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 60652-6030 | 60652-6030-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:579 | 579 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:579 | 579 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1033 | 73013-1033-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:579 | 579 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5028 | 26436-5028-3 | Glutathione | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:579 | 579 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-157 | 73177-157-03 | Furosemide | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:579 | 579 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:579 | 579 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-1:579 | 579 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:579 | 579 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6516 | 72934-6516-2 | Hydroquinone; Tretinoin | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:579 | 579 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0413 | 71285-0413-1 | Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Dextrose Monohydrate; Histidine; Arginine; Taurine; Leucine; Methionine; Proline; Aspartic Acid | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:580 | 580 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 72682-6858 | 72682-6858-1 | PlenishIV Nutrient Cocktail 50mL | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:580 | 580 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diethylstilbestrol | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:580 | 580 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:580 | 580 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-289 | 70004-289-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:580 | 580 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-1 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:580 | 580 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5050 | 71266-5050-1 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:580 | 580 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:580 | 580 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-293 | 70092-293-49 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:580 | 580 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1041 | 73013-1041-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:580 | 580 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70657-1014 | 70657-1014-3 | Glutathione | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:580 | 580 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71300-6440 | 71300-6440-2 | Gabapentin | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:580 | 580 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:580 | 580 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-546 | 70092-546-35 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:580 | 580 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:580 | 580 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6515 | 72934-6515-2 | Hydroquinone; Tretinoin | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:580 | 580 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0432 | 71285-0432-1 | Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:581 | 581 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 69194-117 | 69194-117-10 | 117 NOREPINEPHRINE 32 MG/250ML 10CT | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:581 | 581 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69623-245 | 69623-245-28 | Dihydroergotamine Mesylate | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:581 | 581 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:581 | 581 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-251 | 70004-251-64 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:581 | 581 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-2 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:581 | 581 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-2:581 | 581 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:581 | 581 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:581 | 581 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:581 | 581 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-104 | 73198-104-30 | Glutathione; Ascorbic Acid; Zinc Sulfate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:581 | 581 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-8029 | 72196-8029-1 | Glutamic Acid; Aspartic Acid | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:581 | 581 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:581 | 581 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-112 | 70092-112-49 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:581 | 581 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-05 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:581 | 581 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-6522 | 72934-6522-2 | Hydroquinone; Tretinoin; Hydrocortisone | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:581 | 581 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 80098-030 | 80098-030-90 | Isosulfan Blue | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:582 | 582 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-286 | 70092-286-74 | HydromorphPF 0.2 mg/ml 50ml NS CADDFSFF | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:582 | 582 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-615 | 68985-615-91 | Diltiazem Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:582 | 582 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:582 | 582 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:582 | 582 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2020-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2021-1:582 | 582 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-7 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:582 | 582 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2080 | 71286-2080-2 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:582 | 582 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:582 | 582 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9115 | 71266-9115-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:582 | 582 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-103 | 73198-103-10 | Glycerin | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:582 | 582 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0413 | 72196-0413-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:582 | 582 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:582 | 582 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-293 | 70092-293-49 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:582 | 582 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-30 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:582 | 582 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydroxocobalamin | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:582 | 582 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-6000 | 26436-6000-1 | Isotonic Sodium Chloride Solution | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:583 | 583 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83155-109 | 83155-109-25 | Phenylephrine Hydrochloride | 2026-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:583 | 583 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:583 | 583 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:583 | 583 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:583 | 583 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-07 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:583 | 583 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-1 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:583 | 583 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:583 | 583 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-116 | 70092-116-75 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:583 | 583 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70214-3011 | 70214-3011-1 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:583 | 583 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Glycerin | 2023-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-2:583 | 583 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0405 | 72196-0405-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:583 | 583 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:583 | 583 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-115 | 70092-115-36 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:583 | 583 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-1032 | 73013-1032-1 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:583 | 583 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2434 | 72627-2434-2 | Hydroxocobalamin | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:583 | 583 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1531 | 72934-1531-2 | Ivermectin; Metronidazole | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:584 | 584 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-169 | 73177-169-26 | Sodium Chloride | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:584 | 584 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:584 | 584 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:584 | 584 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:584 | 584 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-103 | 73177-103-05 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:584 | 584 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2071 | 71286-2071-3 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:584 | 584 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:584 | 584 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:584 | 584 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:584 | 584 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73198-134 | 73198-134-10 | Glycerin; Lidocaine Hydrochloride | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:584 | 584 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0419 | 72196-0419-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:584 | 584 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:584 | 584 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-287 | 70092-287-35 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:584 | 584 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-687 | 70092-687-48 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:584 | 584 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-1541 | 72934-1541-2 | Ibuprofen; Salicylic Acid | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:584 | 584 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:585 | 585 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 83863-0600 | 83863-0600-2 | Hydromorphone HCl 10 mg in NS 50 mL (0.2 mg/mL) | 2025-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:585 | 585 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 5446-1086 | 5446-1086-03 | Diltiazem Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:585 | 585 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:585 | 585 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 61141-4836 | 61141-4836-1 | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | valid | 0 | 2026-10-15 | |
outsourcing:2020-2:585 | 585 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-05 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:585 | 585 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2001 | 71286-2001-2 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:585 | 585 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5040 | 71266-5040-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:585 | 585 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-112 | 70092-112-49 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:585 | 585 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:585 | 585 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72627-2416 | 72627-2416-1 | Glycine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:585 | 585 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0420 | 72196-0420-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:585 | 585 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:585 | 585 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-286 | 70092-286-74 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:585 | 585 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2025-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2025-2:585 | 585 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72934-4613 | 72934-4613-9 | Ibuprofen; Terbinafine Hydrochloride; Fluconazole; Itraconazole | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:585 | 585 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Ketamine | 2026-1 | source_no_ndc | 1 | 2026-10-15 | |||
compounder:586 | 586 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9160 | 71266-9160-2 | Bupivacaine | 2025-1 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:586 | 586 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Diltiazem Hydrochloride | 2019-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2019-2:586 | 586 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:586 | 586 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:586 | 586 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-02 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:586 | 586 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2074 | 71286-2074-1 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:586 | 586 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5005 | 71266-5005-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:586 | 586 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-17 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:586 | 586 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2023-1:586 | 586 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 26436-5227 | 26436-5227-3 | Glycine | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:586 | 586 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 72196-0428 | 72196-0428-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:586 | 586 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2024-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2024-2:586 | 586 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-118 | 70092-118-50 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:586 | 586 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-3 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:586 | 586 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-140 | 73702-140-71 | Indomethacin | 2025-2 | valid | 0 | 2026-10-15 | |
outsourcing:2026-1:586 | 586 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-302 | 73702-302-31 | Ketamine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:587 | 587 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 81483-0044 | 81483-0044-0 | Albuterol Sulfate | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:587 | 587 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-541 | 70004-541-35 | Diltiazem Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:587 | 587 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2019-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-1:587 | 587 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:587 | 587 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-102 | 73177-102-03 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:587 | 587 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-7 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:587 | 587 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5050 | 71266-5050-1 | Fentanyl Citrate | 2021-2 | valid | 0 | 2026-10-15 | |
outsourcing:2022-1:587 | 587 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Hydromorphone Hydrochloride | 2022-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-2:587 | 587 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-01 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 | |
outsourcing:2023-1:587 | 587 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-083 | 70092-083-44 | Glycopyrrolate | 2023-1 | valid | 0 | 2026-10-15 | |
outsourcing:2023-2:587 | 587 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71285-0420 | 71285-0420-1 | Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium | 2023-2 | valid | 0 | 2026-10-15 | |
outsourcing:2024-1:587 | 587 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 68985-234 | 68985-234-91 | Hydromorphone Hydrochloride | 2024-1 | valid | 0 | 2026-10-15 | |
outsourcing:2024-2:587 | 587 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70092-290 | 70092-290-49 | Hydromorphone Hydrochloride | 2024-2 | valid | 0 | 2026-10-15 | |
outsourcing:2025-1:587 | 587 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-9110 | 71266-9110-4 | Hydromorphone Hydrochloride | 2025-1 | valid | 0 | 2026-10-15 | |
outsourcing:2025-2:587 | 587 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Inositol; Choline Chloride; Cyanocobalamin; Pyridoxine Hydrochloride; Methionine | 2025-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2026-1:587 | 587 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73702-301 | 73702-301-10 | Ketamine | 2026-1 | valid | 0 | 2026-10-15 | |
compounder:588 | 588 | compounder | ndc_compounder_zip | package | COMPOUNDER | Outsourcing facility compounded drug report | 73013-2002 | 73013-2002-2 | Ketamine Hydrochloride 10mg/mL | 2024-2 | valid | 0 | 2026-09-18 | |
outsourcing:2019-1:588 | 588 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 70004-540 | 70004-540-35 | Diltiazem Hydrochloride | 2019-1 | valid | 0 | 2026-10-15 | |
outsourcing:2019-2:588 | 588 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-523 | 69374-523-25 | Fentanyl Citrate | 2019-2 | valid | 0 | 2026-10-15 | |
outsourcing:2020-1:588 | 588 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate; Bupivacaine Hydrochloride | 2020-1 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2020-2:588 | 588 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71266-5045 | 71266-5045-2 | Fentanyl Citrate | 2020-2 | valid | 0 | 2026-10-15 | |
outsourcing:2021-1:588 | 588 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 71286-2003 | 71286-2003-1 | Fentanyl Citrate | 2021-1 | valid | 0 | 2026-10-15 | |
outsourcing:2021-2:588 | 588 | compounder | outsourcing_history | report | COMPOUNDER | Outsourcing facility compounded drug report | Fentanyl Citrate | 2021-2 | source_no_ndc | 1 | 2026-10-15 | |||
outsourcing:2022-1:588 | 588 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 69374-559 | 69374-559-50 | Hydromorphone Hydrochloride | 2022-1 | valid | 0 | 2026-10-15 | |
outsourcing:2022-2:588 | 588 | compounder | outsourcing_history | package | COMPOUNDER | Outsourcing facility compounded drug report | 73177-104 | 73177-104-03 | Hydromorphone Hydrochloride | 2022-2 | valid | 0 | 2026-10-15 |